Immunogenicity and antibody formation after onabotulinumtoxinA treatments were evaluated for toxin-neutralizing antibodies from serum samples collected in phase 2 studies.
Bisubstrate analog inhibitors in which a nicotinamide mimic is attached to a series of structurally diversified guanidines (arginine mimics) were synthesized and evaluated for inhibition of cholera toxin.
Two botulinum toxins A have been evaluated for the treatment of refractory neurogenic detrusor overactivity (NDO) in humans: Dysport (abobotulinumtoxinA) and Botox (onabotulinumtoxinA).
EGF and diphtheria toxin fusion proteins have been evaluated for their ability to induce regressions of subcutaneous human glioblastomas in athymic nude mice [8].
Stool samples were evaluated for hipO (C. jejuni), ask (C. coli), and cdtABC (C. jejuni's cytolethal distending toxin) genes.
Several β-cyclodextrin derivatives were evaluated for their ability to protect RAW 264.7 cells from the action of anthrax lethal toxin.
Animals were also tested for serum antibodies against dermonecrotic toxin (anti-DNT Ab) produced by Pm and nasal swabs from all piglets were evaluated for the presence of toxigenic Pm according to procedures described below.
"Most artists are evaluated for themselves.
Data were evaluated for normality.
In separate experiments, Caco-2 cells were treated with BoNT/A toxins in the presence or absence of the HA-C for only 1 h to evaluate the time required for toxin binding and internalization.
In order to evaluate the toxin activation by HCV protease in-vivo, our model cell lines, induced or uninduced for NS3 expression, were treated with "PE-DTA-cleavage site-defensin" or "PE-DTA-mutated cleavage site- defensin".
